A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis (Q44001976)

28 November 2017

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis (English)

1 reference

28 November 2017

Carmine M Pariante

1

0 references

Stafford Lightman

object named as

Stafford Lightman

7

0 references

author name string

Andrew S Papadopoulos

2

1 reference

28 November 2017

Lucia Poon

3

1 reference

28 November 2017

Stuart A Checkley

4

1 reference

28 November 2017

Judie English

5

1 reference

28 November 2017

Robert W Kerwin

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

28 November 2017

Biological Psychiatry

1 reference

28 November 2017

51

1 reference

28 November 2017

11

1 reference

28 November 2017

922-930

1 reference

A Radioreceptor Assay for Evaluation of the Plasma Glucocorticoid Activity of Natural and Synthetic Steroids in Man1

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Salivary cortisol during opiate dependence and withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Tissue specificity of glucocorticoid sensitivity in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Anxiety and the dexamethasone suppression test monitored with saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

The corticosteroid receptor hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Salivary cortisol: a practical method for evaluation of adrenal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Salivary cortisol in psychoneuroendocrine research: recent developments and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Binding of Steroids to Mineralocorticoid Receptors: Implications for in Vivo Occupancy by Glucocorticoids*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Mineralocorticoid receptor-like aldosterone-binding protein in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

The brain mineralocorticoid receptor: greedy for ligand, mysterious in function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

The DST as a predictor of outcome in depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Clinical and metabolic effects of dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Relative glucocorticoid potency revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

Loss of Glucocorticoid Fast Feedback in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901314-2

10.1016/S0006-3223(01)01314-2

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference